Debu Tripathy, MD

Debu Tripathy discuss how to encouragecompliance and adherence for patients with breast cancer who are receiving hormone therapy.

Debu Tripathy on the management of patients with breast cancer on oral oncolytics.

Dr. Debu Tripathy discusses the common treatments to help prevent recurrence of early stage breast cancer.

Debu Tripathy, MD, chair of the Department of Breast Medical Oncology at University of Texas MD Anderson Cancer Center, discusses the potential for using breast cancer tumor DNA to make treatment decisions.

Debu Tripathy, MD, chair of the Department of Breast Medical Oncology at University of Texas MD Anderson Cancer Center, discusses genetic risk for breast cancer, the strongest factor in determining if an individual will develop the disease.

Debu Tripathy, MD, chair, Department of Breast Medical Oncology at The University of Texas MD Anderson Cancer Center, discusses hormonal therapy for advanced and early-stage breast cancer.

Debu Tripathy, MD, chair of the Department of Breast Medical Oncology at The University of Texas MD Anderson Cancer Center, discusses the development of palbociclib (Ibrance) in breast cancer.